Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

KEA requests State government to prevent engineering seat blocking racket by ensuring all vacant seats are allotted through ...

Vislink Technologies, Inc. ( NASDAQ: VISL) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Mickey Miller - Chief Executive Officer Mike Bond - Chief Financial Officer ...

Too many of us are dying, presenting with it too late ... The Cancer Equals campaign Greene is supporting was launched by ...

Top 15. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Independent re/insurance broker BMS Group has introduced BMS Bacchus, a stock throughput insurance solution designed to ...

Following AbbVie’s announcement, as its stock price fell, BMS’s rose by over 11%. According to GlobalData’s expiry model, ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

AbbVie's emraclidine trials for schizophrenia fail, leading to stock decline, but analysts maintain confidence in the company ...

Bristol-Myers Squibb's Cobenfy comes out as the major beneficiary and will ... and the next steps taken by AbbVie will tell ...